These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30721319)

  • 41. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells.
    Hida N; Nishiyama N; Miyoshi S; Kira S; Segawa K; Uyama T; Mori T; Miyado K; Ikegami Y; Cui C; Kiyono T; Kyo S; Shimizu T; Okano T; Sakamoto M; Ogawa S; Umezawa A
    Stem Cells; 2008 Jul; 26(7):1695-704. PubMed ID: 18420831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Menstrual Blood-Derived Mesenchymal Stem Cells: Women's Attitudes, Willingness, and Barriers to Donation of Menstrual Blood.
    Manley H; Sprinks J; Breedon P
    J Womens Health (Larchmt); 2019 Dec; 28(12):1688-1697. PubMed ID: 31397634
    [No Abstract]   [Full Text] [Related]  

  • 43. Novel therapeutic strategies for injured endometrium: intrauterine transplantation of menstrual blood‑derived cells from infertile patients.
    Hosoya S; Yokomizo R; Kishigami H; Fujiki Y; Kaneko E; Amita M; Saito T; Kishi H; Sago H; Okamoto A; Umezawa A
    Stem Cell Res Ther; 2023 Oct; 14(1):297. PubMed ID: 37840125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced therapeutic potential of Flotillins-modified MenSCs by improve the survival, proliferation and migration.
    Cheng F; Ji L; Li P; Han Z; He Y; Yang F; Xu Z; Li Y; Ruan T; Zhu X; Lin J
    Mol Biol Rep; 2024 May; 51(1):680. PubMed ID: 38796595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sustainable Production and Activity Determination of Serum-Free Conditioned Medium from Menstrual Blood-Derived Endometrial Stem Cells.
    Shang L; Zhang R; Yan J; Lu Y; Zhang S; Sun Y; Cheng H; Liu Y; Lin J
    Appl Biochem Biotechnol; 2023 Feb; 195(2):1109-1121. PubMed ID: 36327033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human amnion mesenchymal stem cells promote endometrial repair via paracrine, preferentially than transdifferentiation.
    Huang X; Yang X; Huang J; Wei L; Mao Y; Li C; Zhang Y; Chen Q; Wu S; Xie L; Sun C; Zhang W; Wang J
    Cell Commun Signal; 2024 May; 22(1):301. PubMed ID: 38822356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Menstrual Blood-Derived Stem Cells: In Vitro and In Vivo Characterization of Functional Effects.
    Rodrigues MC; Lippert T; Nguyen H; Kaelber S; Sanberg PR; Borlongan CV
    Adv Exp Med Biol; 2016; 951():111-121. PubMed ID: 27837558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Method to Repair Thin Endometrium and Restore Fertility Based on Menstruation-Derived Stem Cell.
    Chen K; Wang H; Zhao X; Wang J; Jin Q; Tong X; Zheng S
    Reprod Sci; 2024 Jun; 31(6):1662-1673. PubMed ID: 38294669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Menstrual blood-derived endometrial stem cells ameliorate the viability of ovarian granulosa cells injured by cisplatin through activating autophagy.
    Fu X; Zhang S; Li T; Zhang R; Lu Y; Cheng H; Xu Y; Qin H; Liu Y; Lin J
    Reprod Toxicol; 2022 Jun; 110():39-48. PubMed ID: 35346788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in stem cell therapy for cardiovascular disease (Review).
    Sun R; Li X; Liu M; Zeng Y; Chen S; Zhang P
    Int J Mol Med; 2016 Jul; 38(1):23-9. PubMed ID: 27220939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization and chondrogenic differentiation of menstrual blood-derived stem cells on a nanofibrous scaffold.
    Kazemnejad S; Akhondi MM; Soleimani M; Zarnani AH; Khanmohammadi M; Darzi S; Alimoghadam K
    Int J Artif Organs; 2012 Jan; 35(1):55-66. PubMed ID: 22307334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A collagen scaffold loaded with human umbilical cord-derived mesenchymal stem cells facilitates endometrial regeneration and restores fertility.
    Xin L; Lin X; Pan Y; Zheng X; Shi L; Zhang Y; Ma L; Gao C; Zhang S
    Acta Biomater; 2019 Jul; 92():160-171. PubMed ID: 31075515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endometrial stem/progenitor cells and their roles in immunity, clinical application, and endometriosis.
    Kong Y; Shao Y; Ren C; Yang G
    Stem Cell Res Ther; 2021 Aug; 12(1):474. PubMed ID: 34425902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myocardial regeneration of the failing heart.
    Akhmedov AT; Marín-García J
    Heart Fail Rev; 2013 Nov; 18(6):815-33. PubMed ID: 23001638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proliferation and chondrogenic differentiation potential of menstrual blood- and bone marrow-derived stem cells in two-dimensional culture.
    Khanmohammadi M; Khanjani S; Bakhtyari MS; Zarnani AH; Edalatkhah H; Akhondi MM; Mirzadegan E; Kamali K; Alimoghadam K; Kazemnejad S
    Int J Hematol; 2012 May; 95(5):484-93. PubMed ID: 22527849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modified protocol for improvement of differentiation potential of menstrual blood-derived stem cells into adipogenic lineage.
    Khanmohammadi M; Khanjani S; Edalatkhah H; Zarnani AH; Heidari-Vala H; Soleimani M; Alimoghaddam K; Kazemnejad S
    Cell Prolif; 2014 Dec; 47(6):615-23. PubMed ID: 25252214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study.
    Santamaria X; Cabanillas S; Cervelló I; Arbona C; Raga F; Ferro J; Palmero J; Remohí J; Pellicer A; Simón C
    Hum Reprod; 2016 May; 31(5):1087-96. PubMed ID: 27005892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toward personalized cell therapies: autologous menstrual blood cells for stroke.
    Rodrigues MC; Glover LE; Weinbren N; Rizzi JA; Ishikawa H; Shinozuka K; Tajiri N; Kaneko Y; Sanberg PR; Allickson JG; Kuzmin-Nichols N; Garbuzova-Davis S; Voltarelli JC; Cruz E; Borlongan CV
    J Biomed Biotechnol; 2011; 2011():194720. PubMed ID: 22162629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells.
    Alcayaga-Miranda F; Cuenca J; Luz-Crawford P; Aguila-Díaz C; Fernandez A; Figueroa FE; Khoury M
    Stem Cell Res Ther; 2015 Mar; 6(1):32. PubMed ID: 25889741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic strategies involving uterine stem cells in reproductive medicine.
    Simoni M; Taylor HS
    Curr Opin Obstet Gynecol; 2018 Jun; 30(3):209-216. PubMed ID: 29652725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.